OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $408,239 | -35.3% | 130,016 | +6.4% | 0.00% | -100.0% |
| Q2 2023 | $630,670 | +110933.5% | 122,223 | +13.3% | 0.00% | 0.0% |
| Q1 2023 | $568 | +99.3% | 107,835 | +6.4% | 0.00% | – |
| Q4 2022 | $285 | -99.9% | 101,343 | +2.0% | 0.00% | -100.0% |
| Q3 2022 | $412,000 | +13.2% | 99,332 | +9.8% | 0.00% | 0.0% |
| Q2 2022 | $364,000 | -17.1% | 90,495 | +2.1% | 0.00% | 0.0% |
| Q1 2022 | $439,000 | -27.7% | 88,667 | +1.8% | 0.00% | 0.0% |
| Q4 2021 | $607,000 | -31.8% | 87,118 | -2.1% | 0.00% | 0.0% |
| Q3 2021 | $890,000 | -26.3% | 88,962 | +4.5% | 0.00% | -50.0% |
| Q2 2021 | $1,207,000 | -12.0% | 85,117 | +1.9% | 0.00% | 0.0% |
| Q1 2021 | $1,371,000 | -22.7% | 83,526 | -2.6% | 0.00% | 0.0% |
| Q4 2020 | $1,774,000 | +229.7% | 85,715 | +21.2% | 0.00% | +100.0% |
| Q3 2020 | $538,000 | -15.4% | 70,740 | -7.4% | 0.00% | 0.0% |
| Q2 2020 | $636,000 | +124.7% | 76,395 | +33.4% | 0.00% | 0.0% |
| Q1 2020 | $283,000 | +28.6% | 57,254 | +2.8% | 0.00% | – |
| Q4 2019 | $220,000 | +41.9% | 55,710 | +9.6% | 0.00% | – |
| Q3 2019 | $155,000 | -29.9% | 50,846 | +1.2% | 0.00% | – |
| Q2 2019 | $221,000 | +31.5% | 50,241 | +19.0% | 0.00% | – |
| Q1 2019 | $168,000 | -2.9% | 42,224 | -2.9% | 0.00% | – |
| Q4 2018 | $173,000 | -13.1% | 43,465 | +50.3% | 0.00% | – |
| Q3 2018 | $199,000 | -2.5% | 28,914 | -4.3% | 0.00% | – |
| Q2 2018 | $204,000 | +36.9% | 30,202 | +31.6% | 0.00% | – |
| Q1 2018 | $149,000 | +56.8% | 22,947 | +7.6% | 0.00% | – |
| Q4 2017 | $95,000 | -48.4% | 21,322 | -28.5% | 0.00% | – |
| Q3 2017 | $184,000 | -27.6% | 29,835 | +8.9% | 0.00% | -100.0% |
| Q2 2017 | $254,000 | +22.1% | 27,386 | +22.1% | 0.00% | – |
| Q1 2017 | $208,000 | +31.6% | 22,428 | +18.4% | 0.00% | – |
| Q4 2016 | $158,000 | +73.6% | 18,935 | +42.5% | 0.00% | – |
| Q3 2016 | $91,000 | +40.0% | 13,284 | +1.8% | 0.00% | – |
| Q2 2016 | $65,000 | -54.9% | 13,054 | -12.7% | 0.00% | – |
| Q1 2016 | $144,000 | +2.9% | 14,954 | 0.0% | 0.00% | – |
| Q4 2015 | $140,000 | -15.2% | 14,954 | +27.1% | 0.00% | -100.0% |
| Q3 2015 | $165,000 | -24.0% | 11,769 | +14.0% | 0.00% | 0.0% |
| Q2 2015 | $217,000 | – | 10,325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |